Stock Analiz

Moleculin Biotech, Inc. (MBRX) stock forecast and price target

Price $7.87 · data as of November 13, 2026

12-month price target

Average target$240.00
Upside / downside+2949.6%
Analysts3
ConsensusNone
Low $40.00Average $240.00High $620.00

Gold marker: average target · white marker: today’s price ($7.87)

Analyst ratings

Strong buy 1Buy 2Hold 0Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-65.33—$0
Next fiscal year
ends December 31, 2027
$-23.40—$0
Next quarter
ends December 31, 2026
$-8.53—$0
Quarter after
ends March 31, 2027
$-8.20—$0

Consensus of the analysts covering Moleculin Biotech, updated daily. In the last 30 days 2 estimates were raised and 0 lowered.

Frequently asked questions

What is the Moleculin Biotech stock price target?

The average 12-month target from 3 analysts is $240.00, 2949.6% above the current price of $7.87 Targets range from $40.00 to $620.00.

Is Moleculin Biotech a buy according to analysts?

The consensus rating is “None” (1 strong buy, 2 buy). Ratings are opinions, not guarantees; this is not investment advice.

How much is Moleculin Biotech expected to earn?

Analysts expect EPS of $-65.33 for the fiscal year ending December 31, 2026 and $-23.40 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.